<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of Clinical and Experimental Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Annals of Clinical and Experimental Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Анналы клинической и экспериментальной неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-5473</issn><issn publication-format="electronic">2409-2533</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">84</article-id><article-id pub-id-type="doi">10.17816/psaic84</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Technologies</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Технологии</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">A new approach for stroke prevention in Russia</article-title><trans-title-group xml:lang="ru"><trans-title>Новый подход к профилактике инсульта в России</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Feigin</surname><given-names>V. L.</given-names></name><name xml:lang="ru"><surname>Фейгин</surname><given-names>В. Л.</given-names></name></name-alternatives><address><country country="NZ">New Zealand</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Varakin</surname><given-names>Yu. Ya.</given-names></name><name xml:lang="ru"><surname>Варакин</surname><given-names>Юрий Яковлевич</given-names></name></name-alternatives><address><country country="NZ">New Zealand</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kravchenko</surname><given-names>Mikhail A.</given-names></name><name xml:lang="ru"><surname>Кравченко</surname><given-names>Михаил Андреевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6338-0392</contrib-id><name-alternatives><name xml:lang="en"><surname>Piradov</surname><given-names>Mikhail A.</given-names></name><name xml:lang="ru"><surname>Пирадов</surname><given-names>Михаил Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Professor, Full Member of the Russian Academy of Sciences, Director</p></bio><bio xml:lang="ru"><p>д.м.н., проф., академик РАН, директор</p></bio><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5883-8119</contrib-id><name-alternatives><name xml:lang="en"><surname>Tanashyan</surname><given-names>Marine M.</given-names></name><name xml:lang="ru"><surname>Танашян</surname><given-names>Маринэ Мовсесовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof., Corresponding member of RAS, Deputy Director for science, Head, 1<sup>st</sup> Neurological department</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, член-корреспондент РАН, зам. директора по научной работе, рук. 1-го неврологического отделения</p></bio><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gnedovskaya</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Гнедовская</surname><given-names>Елена Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Stakhovskaya</surname><given-names>L. V.</given-names></name><name xml:lang="ru"><surname>Стаховская</surname><given-names>Л. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff5"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shamalov</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Шамалов</surname><given-names>Н. A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff6"/></contrib><contrib contrib-type="author"><name><surname>Krishnamurthi</surname><given-names>R.</given-names></name><address><country country="NZ">New Zealand</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Bhattacharjee</surname><given-names>R.</given-names></name><address><country country="NZ">New Zealand</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Parmar</surname><given-names>P.</given-names></name><address><country country="NZ">New Zealand</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Hussein</surname><given-names>T.</given-names></name><address><country country="NZ">New Zealand</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Barker-Collo</surname><given-names>S.</given-names></name><address><country country="NZ">New Zealand</country></address><email>in-epid@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Institute for Stroke and Applied Neurosciences at AUT University</institution></aff><aff><institution xml:lang="ru">Национальный институт инсульта и прикладных нейронаук в Оклендском Технологическом университете</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">University of Washington</institution></aff><aff><institution xml:lang="ru">Университет Вашингтона</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Novosibirsk State Medical University</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО Новосибирский государственный медицинский университет Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Research Center of Neurology</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Научный центр неврологии»</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Research Institute of Cerebrovascular Pathology
and Stroke</institution></aff><aff><institution xml:lang="ru">НИИ цереброваскулярной патологии и инсульта и кафедра фундаментальной и клинической неврологии и нейрохирургии медико-биологического факультета ГБОУ ВПО РНИМУ им. Н.И. Пирогова</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">N.I. Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">НИИ цереброваскулярной патологии и инсульта и кафедра фундаментальной и клинической неврологии и нейрохирургии медико-биологического факультета ГБОУ ВПО РНИМУ им. Н.И. Пирогова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-12-07" publication-format="electronic"><day>07</day><month>12</month><year>2015</year></pub-date><volume>9</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>19</fpage><lpage>23</lpage><history><date date-type="received" iso-8601-date="2017-01-31"><day>31</day><month>01</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Feigin V.L., Varakin Y.Y., Kravchenko M.A., Piradov M.A., Tanashayan M.M., Gnedovskaya E.V., Stakhovskaya L.V., Shamalov N.A., Krishnamurthi R.-., Bhattacharjee R.-., Parmar P.-., Hussein T.-., Barker-Collo S.-.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Feigin V.L., Varakin Y.Y., Kravchenko M.A., Piradov M.A., Tanashayan M.M., Gnedovskaya E.V., Stakhovskaya L.V., Shamalov N.A., Krishnamurthi R.-., Bhattacharjee R.-., Parmar P.-., Hussein T.-., Barker-Collo S.-.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Feigin V.L., Varakin Y.Y., Kravchenko M.A., Piradov M.A., Tanashayan M.M., Gnedovskaya E.V., Stakhovskaya L.V., Shamalov N.A., Krishnamurthi R.-., Bhattacharjee R.-., Parmar P.-., Hussein T.-., Barker-Collo S.-.</copyright-holder><copyright-holder xml:lang="ru">Feigin V.L., Varakin Y.Y., Kravchenko M.A., Piradov M.A., Tanashayan M.M., Gnedovskaya E.V., Stakhovskaya L.V., Shamalov N.A., Krishnamurthi R.-., Bhattacharjee R.-., Parmar P.-., Hussein T.-., Barker-Collo S.-.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://annaly-nevrologii.com/pathID/article/view/84">https://annaly-nevrologii.com/pathID/article/view/84</self-uri><abstract xml:lang="en"><p>The growing burden of stroke in Russia, along with the increasing cost of healthcare calls for new, more effective strategies for stroke prevention. These strategies should include increasing awareness of stroke symptoms, awareness of risk factors, and provision of easily available information on means of modifying risk factors. The Stroke Riskometer App is exactly such a tool, available in Russian, for adult individuals to calculate their risk of stroke over the next 5 and 10 years and identify their individual stroke risk factors and linking them to possible means of modifying these risk factors. The use of this App could reduce the risk of stroke for individuals in the Russian population and contribute to significant reduction in stroke burden in Russia</p></abstract><trans-abstract xml:lang="ru"><p>Значительные потери от инсульта в России наряду с постоянным увеличением стоимости медицинской помощи этим больным требуют новых, более эффективных стратегий его профилактики. Эти стратегии должны включать в себя повышение осведомленности населения о симптомах и факторах риска инсульта, а также предоставление легко доступной информации о способах коррекции факторов риска. Предлагаемое приложение для смартфонов «Рискометр™ инсульта» является именно таким инструментом, разработанным на основе научных данных, признанным международным медицинским сообществом и представленным в том числе и на русском языке. Приложение позволяет рассчитать риск инсульта у взрослых на ближайшие 5 или 10 лет, определить индивидуальные факторы риска инсульта, а также предложить возможные способы их коррекции. Широкомасштабное использование данного приложения в Российской Федерации будет реально способствовать снижению заболеваемости инсультом среди населения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>stroke</kwd><kwd>prevention</kwd><kwd>risk factors</kwd><kwd>risk of the stroke</kwd><kwd>Stroke Riskometer App</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>инсульт</kwd><kwd>профилактика</kwd><kwd>факторы риска</kwd><kwd>риск инсульта</kwd><kwd>приложение «Рискометр™ инсульта»</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Ощепкова Е.В. О федеральной целевой программе «Профилактика и лечение АГ в Российской Федерации». Профилактика заболеваний и укрепление здоровья 2002; 1: 3–7.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Стаховская Л.В., Клочихина О.А., Богатырева М.Д., Коваленко В.В. Эпидемиология инсульта в России по результатам территориально-популяционного регистра (2009-2010). Журн.неврол. и психиатрии им. С.С. Корсакова 2013; 113 (5): 4–10.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Суслина З.А., Варакин Ю.Я. Клиническое руководство по ранней диагностике, лечению и профилактике сосудистых заболеваний головного мозга. М.: МЕД пресс-информ, 2015.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Brindle P., Emberson J., Lampe F. et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327 (7426): 1267.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Cox J.L., Carr B., Vallis T.M. et al. A novel approach to cardiovascular health by optimizing risk management (ANCHOR): a primary prevention initiative examining the impact of health risk factor assessment and management on cardiac wellness. Can J Cardiol 2011; 27 (6): 809–817.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>D’Agostino R.B., Wolf P.A., Belanger A.J.et al. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 1994; 25 (1): 40–43.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Ebrahim S., Taylor F., Ward K. et al. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2011; 1: CD001561.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Feigin V.L., Forouzanfar M.H., Krishnamurthi R. et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383 (9913): 245–254.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Goldstein L.B., Bushnell C.D., Adams R.J. et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42(2): 517–584.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hippisley-Cox J., Coupland C., Brindle P. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study. BMJ 2013; 346: 2573.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Naghavi M., Wang H., Lozano R. et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385 (9963): 117–171.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>O’Donnell M.J., Xavier D., Liu L. et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376 (9735): 112–123.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Parmar P., Krishnamurthi R., Ikram M.A. et al. The Stroke Riskometer(TM) App: Validation of a data collection tool and stroke risk predictor. International journal of stroke : official journal of the International Stroke Society 2015; 10 (2): 231–244.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Simons L.A., Simons J., McManus P. et al. Discontinuation rates for use of statins are high. BMJ 2000; 321 (7268): 1084.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Vos T., Barber R.M., Bell B. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386 (9995): 743–800.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Wartak S.A., Friderici J., Lotfi A. et al. Patients’ knowledge of risk and protective factors for cardiovascular disease. Am J Cardiol. 2011; 107 (10): 1480–1488.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>eMarketer Smartphone Users Worldwide Will Total 1.75 Billion in 2014: Mobile users pick up smartphones as they become more affordable, 3G and 4G networks advance 2014 [cited 2014 12 Dec]; Available from: http://www.emarketer.com/Article/Smartphone-Users-Worldwide-Will-Total-175-Billion-2014/1010536.</mixed-citation></ref></ref-list></back></article>
